Cancer glossary
CYFRA 21-1: the lung cancer tumor marker — what it shows and when it helps
CYFRA 21-1 is a fragment of cytokeratin 19, a tumor marker in non-small cell lung cancer. Why it is tested, why it can't diagnose cancer and how to read the trend.
Written and medically reviewed by
Dr. Tara EinullaevaMedical oncologist, 9 years in practice. Credentials · reviewed 19 October 2026
In short
CYFRA 21-1 is a fragment of the protein cytokeratin 19, released by epithelial tumor cells. It is used mainly in non-small cell lung cancer, especially squamous cell.
How it appears in your report
- ‘CYFRA 21-1 2.1 ng/mL (normal up to 3.3)’.
- ‘CYFRA 21-1 — 18.5 ng/mL, down from 42 after 2 cycles’.
What it means
According to the US National Cancer Institute, cytokeratin fragment 21-1 is used to help monitor for recurrence of lung cancer. If the marker was raised before treatment, its trend helps assess the effect; if it was normal, it tells little.
Like other tumor markers, CYFRA 21-1 doesn't make a diagnosis and doesn't replace CT. It is better to compare results from the same lab.
Does it affect treatment
No, treatment decisions are made on CT/PET-CT, pathology and molecular tests (EGFR, ALK, PD-L1). A rising marker is a reason to bring scans forward.
Questions to ask your doctor
- Was my CYFRA 21-1 raised before treatment?
- Is there any point testing it regularly?
- Which molecular tests have been done on my tumor?
Sources
- Tumor Markers in Common Use — National Cancer Institute
- Tumor Markers — National Cancer Institute
FAQ
Related terms
This is reference information and not a substitute for medical advice. Your doctor interprets each value in the context of your whole situation.
